Digest Network Come funziona
Network
/
Società
De
Non verificato

Definium Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VariePsichiatriaSalute

23 comunicati stampa

Guarda tutti i comunicati
01/06/2026
Scienza
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Industria
Definium Therapeutics Announces New Employee Inducement Grants
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
21/05/2026
Web e Social Network
Eventi
Finanza
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Definium Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
12/05/2026
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Psichiatria
Medicina - Varie
Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 ODT in Major Depressive Disorder
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
11/05/2026
Mercato azionario
Finanza
Psichiatria
Salute
Scienza
Farmaceutica
Biotecnologia
Definium Therapeutics Announces New Employee Inducement Grants
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
07/05/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Definium Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
30/04/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Psichiatria
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Definium Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
22/04/2026
Industria
Scienza
Biotecnologia
Farmaceutica
Medicina alternativa
Salute
Psichiatria
Medicina - Varie
Definium Therapeutics Highlights DT120 ODT (Lysergide Tartrate) Clinical Advancements and Commercial Strategy at Investor and Analyst Day
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
20/04/2026
Finanza
Psichiatria
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Definium Therapeutics Announces New Employee Inducement Grants
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
18/04/2026
Industria
Politica Interna
Psichiatria
Salute
Politica Locale
Sanità
Definium Therapeutics Applauds White House Executive Order to Accelerate Mental Health Innovation and Expand Access to Psychedelic Medical Treatments
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0
09/04/2026
Web e Social Network
Eventi
Psichiatria
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Definium Therapeutics to Participate at Upcoming Investor Conferences and Events
Fonte
Definium Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0